Table 1.

Comparison between patients with ANCA-associated vasculitis with and without severe infection. Results are given as mean (± SD) for normally distributed variables and median (IQR) for not normally distributed variables.

CharacteristicsSevere Infection, n = 86No Severe Infection, n = 100p
Age at diagnosis, yrs, mean ± SD68.8 ± 13.560.8 ± 16.8< 0.001
Sex, F:M41:4554:460.4
Diagnosis: GPA/MPA/EGPA47/36/345/47/8
PR3 + ANCA: MPO + ANCA, n = 92: n = 7841:3851:400.5
Laboratory data at diagnosis
  Serum creatinine, μmol/l238 (75–350)117 (73–256)0.01
  Hemoglobin concentration, g/l106 ± 20113 ± 180.03
  White blood cell count11 (9–14)11 (8–14)0.9
  Platelet count370 ± 133391 ± 1360.2
  C-reactive protein, mg/l101 ± 8692 ± 770.4
  ESR, mm/h66 ± 3467 ± 330.9
  *Patients with GFR < 50 ml/min/1.73 m252/75 (69%)47/89 (53%)0.03
Deaths40 (46.5%)26 (26%)0.004
ESRD22 (25.6%)10 (10%)0.002
  • * At diagnosis. ANCA: antineutrophil cytoplasmic antibody; IQR: interquartile range; ESR: erythrocyte sedimentation rate; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis; EGPA: eosinophilic granulomatosis with polyangiitis; PR3: proteinase 3; MPO: myeloperoxidase; GFR: glomerular filtration rate; ESRD: endstage renal disease.